Medication Instructions for Patients: Personalized Dosing of Trastuzumab

Fam-trastuzumab deruxtecan-nxki is a targeted therapy for HER2-positive breast cancer, non-small cell lung cancer and gastric cancer, and its efficacy has been widely recognized around the world. However, many patients may be confused about the exact dosage of this drug. The recommended dose of trastuzumab is not set in stone. For patients with breast cancer and non-small cell lung cancer, the usual recommended dose is 5.4 mg/kg intravenously every three weeks; while for patients with gastric cancer, the recommended dose is slightly higher at 6.4 mg/kg. These recommended doses are based on extensive clinical trials and patient data and are designed to ensure the drug's safety and effectiveness.

However, during the actual treatment process, the doctor will adjust the dosage according to the patient's specific conditions. This includes factors such as the patient's weight, body surface area, liver and kidney function, severity of illness, and tolerance to medications. Therefore, even if two patients receive trastuzumab, their actual dose may differ due to individual differences. Regarding the question "Can trastuzumab be infused 450 mg at a time?", the answer is not absolute. Whether this dose is appropriate for a particular patient depends on the patient's weight and other relevant factors. For example, a dose of 450 mg may be too high for a lighter patient, but may be just right for a heavier patient.

Therefore, it is crucial to emphasize the importance of personalized dosing decisions. Every patient should fully communicate with their doctor to ensure that the dosage used is both safe and effective. At the same time, patients should pay close attention to their physical condition during treatment. If they experience any discomfort or abnormal reactions, they should promptly report to the doctor so that the treatment plan can be adjusted in a timely manner.